Supplementary Table S5 from Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers
Jingjing Jiang,Lingyan Jiang,Benjamin J. Maldonato,Yingyun Wang,Matthew Holderfield,Ida Aronchik,Ian P. Winters,Zeena Salman,Cristina Blaj,Marie Menard,Jens Brodbeck,Zhe Chen,Xing Wei,Michael J. Rosen,Yevgeniy Gindin,Bianca J. Lee,James W. Evans,Stephanie Chang,Zhican Wang,Kyle J. Seamon,Dylan Parsons,James Cregg,Abby Marquez,Aidan C.A. Tomlinson,Jason K. Yano,John E. Knox,Elsa Quintana, Andrew J. Aguirre,Kathryn C. Arbour,Abby Reed,W. Clay Gustafson,Adrian L. Gill,Elena S. Koltun,David Wildes,Jacqueline A.M. Smith,Zhengping Wang,Mallika Singh crossref（2024）
Abstract
Supplementary Table S5 shows time to tumor doubling of individual animals in RMC-6236 mouse clinical trial.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper